Autolus Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress

Go back to Autolus Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
(NASDAQ: AUTL) Delayed: 2.16 -0.08 (3.57%)
Previous Close $2.24    52 Week High
Open $2.22    52 Week Low
Day High $2.23    P/E N/A 
Day Low $2.15    EPS
Volume 1,163,847